Trials / Recruiting
RecruitingNCT06688825
Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This project will be a single-arm feasibility study, with a treatment intervention that includes three interrelated components: (1) patient education using a proven weight loss curriculum, and (2) technology tools for making healthy lifestyle choices.
Detailed description
To optimize care for overweight/obese patients who are awaiting kidney transplants by implementing a referral process and a multi-pronged, team-based nurse/pharmacist/dietitian weight loss treatment intervention to help these patients achieve transplant criteria. Obesity, hypertension, and ESRD disproportionately affect the Black community, and Black patients have been historically disadvantaged by race-inclusive calculations that overestimated their kidney function. Effective January 5, 2023, the Organ Procurement and Transplantation Network Board of Directors requires use of a race-neutral estimated glomerular filtration rate (eGFR) to qualify candidates for kidney transplant. They also required transplant programs to identify Black candidates who may have been wrongly denied qualification
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Education regarding Weight loss | Per American Association of Clinical Endocrinology (AACE) guidelines |
| BEHAVIORAL | Lifestyle tools for weight loss | Calorie App, Continuous GlucosWe Monitor (CGM), Weight Scale, Food Scale |
| BIOLOGICAL | Blood draw | Per American Association of Clinical Endocrinology (AACE) guidelines |
Timeline
- Start date
- 2024-09-16
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2024-11-14
- Last updated
- 2025-11-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06688825. Inclusion in this directory is not an endorsement.